The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of activated AKT and MAPK expression in liver metastases with clinical outcome in colorectal cancer patients receiving irinotecan/cetuximab treatment.
Mario Scartozzi
No relevant relationships to disclose
Riccardo Giampieri
No relevant relationships to disclose
Alessandra Mandolesi
No relevant relationships to disclose
Elena Maccaroni
No relevant relationships to disclose
Michela Del Prete
No relevant relationships to disclose
Luca Faloppi
No relevant relationships to disclose
Alessandro Bittoni
No relevant relationships to disclose
Maristella Bianconi
No relevant relationships to disclose
Eva Galizia
No relevant relationships to disclose
Rosa Rita Silva
No relevant relationships to disclose
Lucio Giustini
No relevant relationships to disclose
Alberto Zaniboni
No relevant relationships to disclose
Roberto Labianca
No relevant relationships to disclose
Italo Bearzi
No relevant relationships to disclose
Stefano Cascinu
No relevant relationships to disclose